Brought to you by 
Takeda California licenses rights to Sea Lane's ConCIRT antibody libraries
18 Jun 2013
Executive Summary
Therapeutic antibody company Sea Lane Biotechnologies LLC has granted Takeda Pharmaceuticals Co. Ltd.’s structure based drug discovery division Takeda California Inc. rights to its ConCIRT antibody libraries for use in the development of new drugs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Drug Discovery Technologies
- Molecular Diversity
-
Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Takeda California licenses rights to Sea Lane's ConCIRT antibody libraries
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice